These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long-time echocardiography follow-up study. Pardos-Gea J; Avegliano G; Evangelista A; Vilardell M; Ordi-Ros J Int J Rheum Dis; 2015 Jan; 18(1):76-83. PubMed ID: 24131635 [TBL] [Abstract][Full Text] [Related]
4. [Affection of cardiovascular system in antiphospholipid syndrome with non-bacterial thrombotic endocarditis]. Demin AA; Chapaeva NN; Trifonova MA Ter Arkh; 2008; 80(8):51-3. PubMed ID: 18807541 [TBL] [Abstract][Full Text] [Related]
5. [Valvular heart disease in patients with anti-phospholipid syndrome]. Muñoz-Rodríguez FJ; Reverter Calatayud JC; Font Franco J; Espinosa Garriga G; Tàssies Penella D; Ingelmo Morin M Rev Clin Esp; 2002 Oct; 202(10):529-33. PubMed ID: 12361550 [TBL] [Abstract][Full Text] [Related]
6. Features associated with epilepsy in the antiphospholipid syndrome. Shoenfeld Y; Lev S; Blatt I; Blank M; Font J; von Landenberg P; Lev N; Zaech J; Cervera R; Piette JC; Khamashta MA; Bertolaccini ML; Hughes GR; Youinou P; Meroni PL; Pengo V; Alves JD; Tincani A; Szegedi G; Lakos G; Sturfelt G; Jönsen A; Koike T; Sanmarco M; Ruffatti A; Ulcova-Gallova Z; Praprotnik S; Rozman B; Lorber M; Chapman J; van-Breda-Vriezman PJ; Damoiseaux J J Rheumatol; 2004 Jul; 31(7):1344-8. PubMed ID: 15229954 [TBL] [Abstract][Full Text] [Related]
7. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study. Perez-Villa F; Font J; Azqueta M; Espinosa G; Pare C; Cervera R; Reverter JC; Ingelmo M; Sanz G Arthritis Rheum; 2005 Jun; 53(3):460-7. PubMed ID: 15934103 [TBL] [Abstract][Full Text] [Related]
8. [Cardiac abnormalities in antiphospholipid syndrome]. Meng XM; Zhao Y; Fang LG; Yan XW Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):284-6. PubMed ID: 17637264 [TBL] [Abstract][Full Text] [Related]
9. Heart Valve Involvement in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Study of a Single Centre. Pons I; Louro J; Sitges M; Vidal B; Cervera R; Espinosa G J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109332 [TBL] [Abstract][Full Text] [Related]
10. [Cardiovascular abnormalities of the antiphospholipid antibody syndrome]. Noureddine M; Bennis A; Raquim S; Tahiri A; Chraibi N Arch Mal Coeur Vaiss; 2003 Apr; 96(4):324-31. PubMed ID: 12741309 [TBL] [Abstract][Full Text] [Related]
11. [Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up]. Reshetniak TM; Alekberova ZS; Kotel'nikova GP; Aleksandrova EN; Mach ES; Radenska-Lopovok SG; Kalashnikova LA; Nasonova VA Ter Arkh; 2003; 75(5):46-51. PubMed ID: 12847898 [TBL] [Abstract][Full Text] [Related]
12. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS"). Asherson RA Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247 [TBL] [Abstract][Full Text] [Related]
13. [Antiphospholipid syndrome in valvular heart diseases, ischemic heart disease and vascular thrombosis]. Grabowski M; Brzezińska A Przegl Lek; 2000; 57(5):296-9. PubMed ID: 11057121 [TBL] [Abstract][Full Text] [Related]
14. Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings. García-Torres R; Amigo MC; de la Rosa A; Morón A; Reyes PA Lupus; 1996 Feb; 5(1):56-61. PubMed ID: 8646227 [TBL] [Abstract][Full Text] [Related]
15. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome. Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704 [TBL] [Abstract][Full Text] [Related]
16. [Involvement of cardiac valves in antiphospholipid syndrome]. Sergakova LM; Fomicheva OA; Vil'chinskaia MI; Alekberova ZS; Aleksandrova EN; Karpov IA; Nasonov EL; At'kov OI Klin Med (Mosk); 1996; 74(9):39-42. PubMed ID: 9121087 [TBL] [Abstract][Full Text] [Related]
17. Valvular heart disease and systemic lupus erythematosus. McCarthy GM; McCarty DJ N Engl J Med; 1997 May; 336(18):1324; author reply 1324-5. PubMed ID: 9132593 [No Abstract] [Full Text] [Related]
18. Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease. Bulckaen HG; Puisieux FL; Bulckaen ED; Di Pompeo C; Bouillanne OM; Watel AA; Fauchais AL; De Groote P; Millaire A Mayo Clin Proc; 2003 Mar; 78(3):294-8. PubMed ID: 12630582 [TBL] [Abstract][Full Text] [Related]
20. What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)? Amigo MC Lupus; 2014 Oct; 23(12):1259-61. PubMed ID: 25228720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]